Bicheng Zhang
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 2%
- Long-Term Effects of COVID-19
Papers in
- Oncology 48
- Cancer Immunotherapy and Biomarkers 14
- Lymphatic System and Diseases 8
- Lung Cancer Research Studies 7
-
- RNA modifications and cancer 11
- Co-authors
- Yuxiao Song (11 shared papers)Jun Wang (10 shared papers)Qibin Song (5 shared papers)Qingzhu Jia (2 shared papers)Xiaoyang Zhou (3 shared papers)Fan Feng (2 shared papers)Yanru Qiu (2 shared papers)Jia Feng (2 shared papers)
- Journals
- Frontiers in Oncology (6 papers)Frontiers in Immunology (5 papers)PLoS ONE (3 papers)Pharmacology (2 papers)Oncology Reports (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Bicheng Zhang
88 papers receiving 2.7k citations
Bicheng Zhang's Hit Papers
Peers
Comparison fields: 5 of 130
- Infectious Diseases 929
- Neurology 468
- Oncology 813
- Immunology 509
- Cancer Research 327
Countries citing papers authored by Bicheng Zhang
This map shows the geographic impact of Bicheng Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bicheng Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bicheng Zhang more than expected).
Fields of papers citing papers by Bicheng Zhang
This network shows the impact of papers produced by Bicheng Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bicheng Zhang. The network helps show where Bicheng Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Bicheng Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical characteristics of 82 cases of death from COVID-19 Hit paper breakdown → | 2020 | 417 |
| 2 | Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19 Hit paper breakdown → | 2020 | 368 |
| 3 | 2020 | 285 | |
| 4 | 2020 | 196 | |
| 5 | 2011 | 151 | |
| 6 | 2014 | 70 | |
| 7 | 2008 | 66 | |
| 8 | 2012 | 62 | |
| 9 | 2009 | 61 | |
| 10 | 2003 | 61 | |
| 11 | 2020 | 58 | |
| 12 | 2014 | 53 | |
| 13 | 2009 | 45 | |
| 14 | 2016 | 40 | |
| 15 | 2008 | 39 | |
| 16 | 2014 | 38 | |
| 17 | 2020 | 37 | |
| 18 | 2003 | 36 | |
| 19 | 2012 | 32 | |
| 20 | 2012 | 31 |
About Bicheng Zhang
Bicheng Zhang is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Immunology, having authored 97 papers that have together received 2.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (15 papers), Cancer Immunotherapy and Biomarkers (14 papers), RNA modifications and cancer (11 papers), Immune cells in cancer (9 papers), Lymphatic System and Diseases (8 papers), COVID-19 Clinical Research Studies (8 papers), Lung Cancer Research Studies (7 papers) and Cancer-related molecular mechanisms research (7 papers). The work is most often cited by research in Infectious Diseases (929 citations), Neurology (468 citations), Oncology (813 citations), Immunology (509 citations) and Cancer Research (327 citations). Bicheng Zhang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yuxiao Song, Jun Wang, Qibin Song, Qingzhu Jia, Xiaoyang Zhou, Fan Feng, Yanru Qiu, Jia Feng, Jianfei Gao and Zhiguo Rao. Their work appears in journals such as Frontiers in Oncology, Frontiers in Immunology, PLoS ONE, Pharmacology and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.